Piekarz Julia, Picheta Natalia, Burdan Oliwia, Kurek Marcelina, Chrościńska-Krawczyk Magdalena
Students' Scientific Association, Department of Paediatric Neurology, Medical University, 20-059 Lublin, Poland.
Department of Children's Neurology, University Children's Hospital, 20-093 Lublin, Poland.
Biomedicines. 2024 Aug 9;12(8):1812. doi: 10.3390/biomedicines12081812.
Alzheimer's disease (AD) affects 50-70% of patients with dementia, making it the leading cause of dementia. The condition is classified as a neurodegenerative, progressive and incurable disease. The disease is affecting more and more people around the world. AD has a multifactorial nature, spreading from beta-amyloid deposition to inflammation in patients' brains. Patients experience cognitive impairment and functional decline. Although it is a disease that occurs mainly in the elderly, it is increasingly being diagnosed in young people between the ages of 30 and 40. It not only affects the patient themself but also reduces the quality of life of their closest caregivers. According to the WHO, the treatment of AD consumes USD 1.3 trillion globally, but it is only symptomatic, as there are no drugs to prevent the onset of AD or treat the cause of its onset. Due to the numerous side effects of therapy and the lack of proactive drugs that act on the pathomechanism of AD, alternative therapies are being sought. One possible option that has many studies confirming its effect is phytotherapy. Many herbs have pharmacological properties, such as antioxidant, anti-inflammatory, or neuroprotective effects, making them the future of cognitive disorders and AD treatment. This review focuses on some of the most promising herbs that have potentially potent properties and effects in AD therapy. These include , , and . These herbs may perhaps be key in the future to make functioning and life easier for patients struggling with AD.
阿尔茨海默病(AD)影响着50%至70%的痴呆症患者,使其成为痴呆症的主要病因。该病症被归类为一种神经退行性、进行性且无法治愈的疾病。这种疾病在全球影响着越来越多的人。AD具有多因素性质,从β-淀粉样蛋白沉积扩散到患者大脑中的炎症。患者会出现认知障碍和功能衰退。尽管它主要是一种发生在老年人身上的疾病,但越来越多地在30至40岁的年轻人中被诊断出来。它不仅影响患者自身,还会降低其最亲密照顾者的生活质量。据世界卫生组织称,全球用于AD治疗的费用高达1.3万亿美元,但这只是对症治疗,因为目前尚无药物能够预防AD的发作或治疗其发病原因。由于治疗存在众多副作用且缺乏作用于AD发病机制的预防性药物,人们正在寻求替代疗法。一种有许多研究证实其效果的可能选择是植物疗法。许多草药具有药理特性,如抗氧化、抗炎或神经保护作用,使其成为认知障碍和AD治疗的未来方向。本综述重点关注一些在AD治疗中具有潜在强大特性和效果的最有前景的草药。这些包括 、 、 和 。这些草药可能在未来成为让与AD作斗争的患者生活和功能更轻松的关键。